CellSens 1.11 - Discover a New Level of Simplicity
Personalised automation is the key to managing complex multi-dimensional experiments, and the latest Olympus cellSens imaging software (version 1.11) seamlessly controls motorised hardware to allow effortless set-up of complex acquisition sequences and protocols. The unique Graphical Experiment Manager (GEM) interface allows the user to "draw" their experimental schematic on-screen with familiar “drag and drop” actions, enabling complete control and experimental set-up of motorised components and accessories with almost no need for training. The capabilities of this intuitive interface are now expanded to the control of motorised stages, enabling the easy automation of multi-position experiments such as individual scanning protocols performed at different positions on a multiwell plate.
Providing insights into a host of biological processes, additional new features of the software include online ratiometric analysis, delivering results in real time and control of rapid focusing devices for fast 3D applications, while also supporting the latest cameras and image-splitter components. From image acquisition to analysis, expanding the range of components compatible with cellSens presents new avenues of exploration within life science. Additional models of EMCCD and sCMOS cameras are now supported such as the Hamamatsu ImagEM X2 and the Andor Zyla 4.2, delivering rapid and sensitive imaging; while 3D applications benefit from the integrated control of piezo-driven devices, for ultra-fast Z-stacking and focusing. Multi-channel imaging of samples with fast dynamics is now supported through the use of an image splitter, with up to four emission channels acquired at the same precise moment. The exact synchronisation of multiple wavelengths also quickly produces reliable images for advanced applications such as FRET and ratiometric analysis. Moreover, ratiometric analysis can now be achieved “online”, enabling the real-time tracking and updating of ratiometric images and graphs during experiments.
These combined features make cellSens version 1.11 ideal for a range of life science imaging applications, enabling any user to rapidly and easily generate reliable results.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance